Download the PDF program
PROVISIONAL PROGRAM
International Scientific Conference: Cancer & Epigenetics – Paris, November 28, 2025
The Cancer & Epigenetics 2025 scientific conference will take place on Friday, November 28 at the Constant Burg Amphitheater, Institut Curie (12 rue Lhomond, 75005 Paris, France). Organized by SIRIC Curie (Institut Curie) and SIRIC EpiCure (Gustave Roussy), this high-level international event is coordinated by
Dr. Céline Vallot and Dr. Sophie Postel-Vinay.
The program will include keynote presentations, a poster session, an exhibition area, and multiple opportunities for networking and collaboration. Join us for this unmissable day focused on the latest advances in cancer epigenetics. The symposium will bring together leading researchers across four major thematic sessions:
8.20-8.30
AM
AM
Dr Céline Vallot & Dr Sophie Postel-Vinay
SIRIC Curie/ SIRIC EpiCure
SIRIC Curie/ SIRIC EpiCure
Welcome and introduction
8.30-10.00 AM
Session I
Targeting Transcription Factors
8.30-9.00
AM
AM
Pr Olivier Delattre, Institut Curie, FR
Gene fusions in cancer, from genetics to immunology
9.00-9.30
AM
AM
Dr Chris Marine, VIB-KU, B
Nongenetic mechanisms of melanoma evolution and therapy resistance
9.30-10.00
AM
AM
Dr Nicolas Bery, CRCT, FR
Targeting hard-to-drug proteins with intracellular antibodies
10.00-10.30
AM
AM
Coffee break and exhibition
10.00-14.00AM
Session II
Epigenetic vulnerabilities
10.30-11.00
AM
AM
Dr Stefan Kubicek, CEMM, AT
Targeting chromatin processes via their subcellular localization
11.00-11.30
AM
AM
Dr Gabriel Malouf, IGBMC, FR
Epigenetic Alterations as Biomarkers and Therapeutic Targets in Renal Cell Carcinomas
11.30-12.00
AM
AM
Dr Mehdi Touat, Siric Curamus, FR
Novel patterns of high-grade transformation in IDH-mutant gliomas
12.00-02.00
PM
PM
Lunch break, exhibition and poster session
02.00-04.00PM
Session III
Immuno-epigenetics
02.00-02.30
PM
PM
Pr Daniel De Carvalho, University of Toronto, CA
Epigenetic deregulation of retroelements as a tumor suppressor mechanism and an emerging therapeutic opportunity
02.30-3.00
PM
PM
Dr Erez Levanon, Bar-Ilan University, IS
A-to-I RNA Editing in Cancer
03.00-03.30
PM
PM
Pr Stéphane Depil, CLB, FR
“Dark genome” and “dark antigens” : probably misnomers but promising targets for cancer im- munotherapy
03.30-04.00
PM
PM
Dr Nada Jabado, McGill University, CA
Oncohistones: Lessons in Hijacking Chromatin Architecture
04.00-04.30
PM
PM
Coffee break and exhibition
04.00-05h30PM
Session IV
Next challenges in cancer epigenetics
04.30-05.00
PM
PM
Dr Franco Izzo, Icahn School of Medicine at Mount Sinai, USA
Genotype to phenotype mapping of human cancers through single-cell multi-omics
05.00-05.30
PM
PM
Dr Rong Fan, Yale School of Medicine USA
Spatially Decoding RNA Regulation and Epigenetics in Human Clinical Archival FFPE Tissues
05.30-06.00
PM
PM
Dr Ekta Khurana, Weill Cornell Medicine, USA
